Morgan Adam — SEC Form 4 filings
SEC reporting owner CIK 1964335. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-03.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-19 to 2026-02-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 2,116,546 shares, $7,182,319 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 350,000 shares @ $12.95 ($4,532,500) in Jasper Therapeutics, Inc., filed 2024-02-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | 10% owner | 1 | 1 leg · 350,000 sh · $4,532,500 | — | — |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | 5 | 1 leg · 1,766,546 sh · $2,649,819 | — | 8 |
| ALIMERA SCIENCES INC (ALIM) | Director, 10% owner | 1 | — | — | 5 |
Form 4 filings — Morgan Adam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2025-08-12 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Purchase (P): 1,766,546 @ $1.50 · Purchase (P): 70,012 (derivative) @ $15 | EDGAR |
| 2025-02-04 | 4/A | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73 | EDGAR |
| 2024-09-16 | 4 | ALIMERA SCIENCES INC (ALIM) jointly with Velan Capital Investment Management LP, Velan Capital Master Fund LP, Velan Capital SPV I LLC, Velan Capital Holdings LLC, Velan Capital Management LLC, VENKATARAMAN BALAJI | Disposition to issuer (D): 9,429,808 · Disposition to issuer (D): 4,178,725 · Disposition to issuer (D): 1,825 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 800,000 (derivative) | EDGAR |
| 2024-02-09 | 4 | Jasper Therapeutics, Inc. (JSPR) jointly with Velan Capital Investment Management LP, Velan Capital Master Fund LP, Avego Healthcare Capital, L.P., Velan Capital Holdings LLC, Avego Healthcare Capital Holdings, LLC, Avego Management LLC, Velan Capital Management LLC, VENKATARAMAN BALAJI | Purchase (P): 350,000 @ $12.95 | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 13,948 @ $0 · Grant/award (A): 83,685 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1964335 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →